Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata available, the FDA issued a warning letter to Quali Controle & Qual-Controle-C.E.Bac on March 5, 2018, regarding an unspecified product category classified as "Other." Without access to the complete warning letter or detailed subject matter, the specific nature of the regulatory violations cannot be determined from the metadata alone. The issuing office information is also unavailable, which limits clarity on the particular regulatory jurisdiction and scope of the citation. Further review of the full warning letter document would be necessary to identify the specific compliance issues and product deficiencies cited by the FDA.